CMS Issues New Guidance on Variable Best Price Reporting under the Medicaid Drug Rebate Program
On March 23, 2022, the Centers for Medicare and Medicaid Services (CMS) released new technical guidance to drug manufacturers and states related to the highly effective Medicaid Drug Rebate Program (MDRP). The guidance is related to a rule finalized late in the Trump Administration that, among other provisions, allowed manufacturers to report a range of […]